Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Mastrantonio

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
Pediatrics|February 7, 2001
Reactogenicity and immunogenicity at preschool age of a booster dose of two three-component diphtheria-tetanus-acellular pertussis vaccines in children primed in infancy with acellular vaccinesA E Tozzi, A Anemona, P Stefanelli, et al.
Journal of Clinical Immunology|May 1, 1990
Antibacterial polysaccharide antibody deficiency after allogeneic bone marrow transplantationI Quinti, A Velardi, S Le Moli, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 18, 2012
Cluster of invasive Neisseria meningitidis infections on a cruise ship, Italy, October 2012P Stefanelli, C Fazio, A Neri, et al.
Developments in Biological Standardization|January 1, 1997
Antibody kinetics and long-term sero-prevalence in the Italian clinical trial of acellular pertussis vaccinesM Giuliano, P Mastrantonio, A Giammanco, et al.
Gut|May 1, 1988
Pathogenesis of postantibiotic diarrhoea caused by Clostridium difficile: an in vitro study in the rabbit intestineS Guandalini, A Fasano, M Migliavacca, et al.
European Journal of Gynaecological Oncology|January 1, 1989
The adjuvant treatment of ovarian cancer: result of the pilot study of a new combination chemotherapeutic regimen (DAC)R V Iaffaioli, G Frasci, G Palmieri, et al.
Vaccine|July 31, 1998
Persistence of protection through 33 months of age provided by immunization in infancy with two three-component acellular pertussis vaccines. Stage II Working GroupS Salmaso, P Mastrantonio, S G Wassilak, et al.
The New Microbiologica|July 29, 1999
Characterization of Bordetella pertussis strains of recent isolationP Stefanelli, L De Marzi, L Robino, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 18, 2003
A European survey of diagnostic methods and testing protocols for Clostridium difficileF Barbut, M Delmée, J S Brazier, et al.
The New England Journal of Medicine|February 8, 1996
A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working GroupD Greco, S Salmaso, P Mastrantonio, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
Pediatrics|February 7, 2001
Reactogenicity and immunogenicity at preschool age of a booster dose of two three-component diphtheria-tetanus-acellular pertussis vaccines in children primed in infancy with acellular vaccinesA E Tozzi, A Anemona, P Stefanelli, et al.
Journal of Clinical Immunology|May 1, 1990
Antibacterial polysaccharide antibody deficiency after allogeneic bone marrow transplantationI Quinti, A Velardi, S Le Moli, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 18, 2012
Cluster of invasive Neisseria meningitidis infections on a cruise ship, Italy, October 2012P Stefanelli, C Fazio, A Neri, et al.
Developments in Biological Standardization|January 1, 1997
Antibody kinetics and long-term sero-prevalence in the Italian clinical trial of acellular pertussis vaccinesM Giuliano, P Mastrantonio, A Giammanco, et al.
Gut|May 1, 1988
Pathogenesis of postantibiotic diarrhoea caused by Clostridium difficile: an in vitro study in the rabbit intestineS Guandalini, A Fasano, M Migliavacca, et al.
European Journal of Gynaecological Oncology|January 1, 1989
The adjuvant treatment of ovarian cancer: result of the pilot study of a new combination chemotherapeutic regimen (DAC)R V Iaffaioli, G Frasci, G Palmieri, et al.
Vaccine|July 31, 1998
Persistence of protection through 33 months of age provided by immunization in infancy with two three-component acellular pertussis vaccines. Stage II Working GroupS Salmaso, P Mastrantonio, S G Wassilak, et al.
The New Microbiologica|July 29, 1999
Characterization of Bordetella pertussis strains of recent isolationP Stefanelli, L De Marzi, L Robino, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 18, 2003
A European survey of diagnostic methods and testing protocols for Clostridium difficileF Barbut, M Delmée, J S Brazier, et al.
The New England Journal of Medicine|February 8, 1996
A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working GroupD Greco, S Salmaso, P Mastrantonio, et al.
Pageof 10